NCT05894954 2026-02-18
EVANTHEA
Alzheimer's Prevention and Reversal Project, Inc.
Phase 3 Completed
Clinical Trials
13 trialsNCT03778931 2025-09-15
EMERALD
Stemline Therapeutics, Inc.
Phase 3 Completed
NCT02330926 2025-08-29
MENAC
Norwegian University of Science and Technology
Phase 3 Completed
NCT03575351 2025-08-03
TRANSFORM
Celgene
Phase 3 Completed
NCT03125070 2025-01-29
INSPIRE
Fred Hutchinson Cancer Center
Phase 3 Completed
NCT02220829 2024-12-09
Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy
Sir Mortimer B. Davis - Jewish General Hospital
Phase 3 Completed
NCT04303013 2023-11-01
Guided Meditation During Radiotherapy.
Mayo Clinic
Phase 3 Completed
NCT00556374 2023-07-27
Study to Determine Treatment Effects of Denosumab in Patients With Breast Cancer Receiving Aromatase Inhibitor Therapy
Amgen
Phase 3 Completed
NCT02039726 2021-02-24
(QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive
Daiichi Sankyo
Phase 3 Completed
NCT02369874 2021-02-10
EAGLE
AstraZeneca
Phase 3 Completed
NCT01917942 2017-07-12
RadioHum
Trans Tasman Radiation Oncology Group
Phase 3 Completed
NCT00003674 2016-07-13
Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00355355 2015-01-30
A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
Light Sciences Oncology
Phase 3 Completed